DrugPatentWatch Database Preview

Bayer Hlthcare Company Profile

« Back to Dashboard

What is the competitive landscape for BAYER HLTHCARE, and what generic alternatives to BAYER HLTHCARE drugs are available?

BAYER HLTHCARE has fifty-five approved drugs.

There are thirty-seven US patents protecting BAYER HLTHCARE drugs.

There are one thousand one hundred and seventy-six patent family members on BAYER HLTHCARE drugs in seventy countries and one hundred and seven supplementary protection certificates in seventeen countries.

Summary for Bayer Hlthcare

International Patents:	1176
US Patents:	37
Tradenames:	55
Ingredients:	36
NDAs:	55

Drugs and US Patents for Bayer Hlthcare

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Bayer Hlthcare	QUINAGLUTE	quinidine gluconate	TABLET, EXTENDED RELEASE;ORAL	016647-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Bayer Hlthcare	YASMIN	drospirenone; ethinyl estradiol	TABLET;ORAL-28	021098-001	May 11, 2001	AB	RX	Yes	Yes	6,787,531		Y
Bayer Hlthcare	ULTRAVIST 240	iopromide	INJECTABLE;INJECTION	020220-003	May 10, 1995		RX	Yes	Yes
Bayer Hlthcare	CIPRO	ciprofloxacin hydrochloride	TABLET;ORAL	019537-001	Apr 8, 1996		DISCN	Yes	No
Bayer Hlthcare	LEVITRA	vardenafil hydrochloride	TABLET;ORAL	021400-002	Aug 19, 2003	AB	RX	Yes	No	7,696,206		Y	Y
Bayer Hlthcare	LEVITRA	vardenafil hydrochloride	TABLET;ORAL	021400-002	Aug 19, 2003	AB	RX	Yes	No	8,841,446		Y

Expired US Patents for Bayer Hlthcare

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Bayer Hlthcare	PRECOSE	acarbose	TABLET;ORAL	020482-001	Sep 6, 1995	4,904,769
Bayer Hlthcare	MAGNEVIST	gadopentetate dimeglumine	INJECTABLE;INJECTION	021037-001	Mar 10, 2000	4,963,344
Bayer Hlthcare	YAZ	drospirenone; ethinyl estradiol	TABLET;ORAL	021676-001	Mar 16, 2006	6,933,395
Bayer Hlthcare	CIPRO	ciprofloxacin hydrochloride	TABLET;ORAL	019537-003	Oct 22, 1987	5,286,754*PED
Bayer Hlthcare	ULTRAVIST 240	iopromide	INJECTABLE;INJECTION	020220-003	May 10, 1995	4,364,921
Bayer Hlthcare	CIPRO	ciprofloxacin hydrochloride	TABLET;ORAL	019537-004	Oct 22, 1987	4,670,444*PED

Paragraph IV (Patent) Challenges for BAYER HLTHCARE drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
	Tablets	0.25 mg/0.5 mg		2015-01-08
	Tablets	3 mg/0.02 mg/0.451 mg and 0.451 mg		2012-11-13
	Tablets	5 mg ad 10 mg		2009-07-10
	Tablets	3 mg; 2 mg/2 mg; 2 mg/3 mg; 1 mg		2010-10-22
	Tablets	25 mg, 50 mg and 100 mg		2005-03-22
	Tablets	40 mg		2016-09-27
	Oral Suspension	250 mg/5 mL and 500 mg/ 5 mL		2009-10-16
	Tablets	3 mg/0.03 mg		2005-01-07
	Orally Disintegrating Tablets	10 mg		2011-12-22
	Tablets	0.5 mg/1 mg		2007-12-26
	Tablets	3 mg/0.02 mg/0.451 mg and 0.451 mg		2011-11-21
	Tablets	20 mg		2009-03-05
	Tablets	2.5 mg		2009-09-04
	Tablets	200 mg		2014-02-28
	Tablets	3 mg/0.03 mg/0.451 mg and 0.451 mg		2012-09-28
	Transdermal System	0.05 mg/day and 0.1 mg/day		2005-09-12
	Tablets	3 mg/0.02 mg		2006-09-29
	Injection	1.6 mg/mL		2014-02-07
	Tablets	0.5 mg, 1 mg,1.5 mg, 2 mg and2.5 mg		2017-10-10

Premature patent expirations for BAYER HLTHCARE

Expiration due to failure to pay maintenance fee

Patent Number	Expiration Date

International Patents for Bayer Hlthcare Drugs

Country	Patent Number	Estimated Expiration
Taiwan	I276436
Croatia	P20050340
Colombia	6630107
Hungary	E026821
Peru	10152006
New Zealand	234295

Supplementary Protection Certificates for Bayer Hlthcare Drugs

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1663978	C20130034 00099	Estonia		PRODUCT NAME: REGORAFENIIB;REG NO/DATE: K(2013)5622 (LOPLIK) 26.08.2013
1140840	C01140840/01	Switzerland		FORMER OWNER: BAYER HEALTHCARE LLC, US
1506193	SPC/GB14/044	United Kingdom		PRODUCT NAME: RIOCIGUAT, I.E. METHYL N-(4,6-DIAMINO-2-(1-(2-FLUOROBENZYL)-1H-PYRAZOLO (3,4-B)PYRIDIN-3-YL)-5-PYRIMIDINYL(METHYL)CARBAMATE,OR A PHARMACEUTICALLY ACCEPTABLE SALT OR HYDRATE THEREOF.; REGISTERED: UK EU/1/13/907 20140331
1380301	SPC019/2009	Ireland		SPC019/2009: 20091119, EXPIRES: 20220628
0405704	C00405704/01	Switzerland		FORMER OWNER: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT, DE
0398460	SPC/GB04/032	United Kingdom		PRODUCT NAME: ESTRADIOL, OPTIONALLY IN THE FORM OF A HYDRATE, TOGETHER WITH DROSPIRENONE; REGISTERED: NL RVG 27505 20021211; UK PL 00053/0341 20040310

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Bayer
• Bayer Healthcare
• Bayer Healthcare Llc
• Bayer Hlthcare
• Bayer Pharms